Navigation Links
Endologix Announces Live Web Cast of Presentation in SMH Capital Small Cap Spotlight on June 17, 2009 at 4:15 p.m. ET
Date:6/15/2009

IRVINE, Calif., June 15 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, today announced that John McDermott, President and CEO, is scheduled to deliver a presentation to the investment community on Wednesday, June 17, 2009 at 4:15 pm ET as part of the SMH Capital Small Cap Spotlight Series. Mr. McDermott will provide a general corporate overview and an update on the Company's recently launched products. He will also participate in a live question and answer session.

Participants can pre-register for the event by visiting the following Web link: https://www2.gotomeeting.com/register/741291363. A live Web cast of the presentation will also be made available on the Investor Relations section of the Endologix Web site at investors.endologix.com.

About Endologix

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's flagship product is the Powerlink(R) System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Additional information can be found on Endologix's Web site at www.endologix.com.

About SMH Market & Liquidity Services

SMH MLS LLC is an affiliate of SMH Capital Inc., a registered broker-dealer and a member of FINRA and SIPC, and a subsidiary of Sanders Morris Harris Group (Nasdaq: SMHG). SMH Market & Liquidity Services assists small cap companies seeking to expand their investor exposure and market depth and breadth through a broad spectrum of services that include comprehensive perspective reports, strategic shareholder communications, and trading analysis. SMH MLS may seek as a client the presenting company of any sponsored webinar. SMH Market & Liquidity Services receives compensation from its company clients for all communications and publications prepared on its behalf (http://www.smhmls.com). SMH MLS may engage SMH Capital to provide research coverage for one of its client. In addition, SMH Capital may provide, or may have provided, any of its services to the subject company, including market making, specialized and other proprietary trading, fund management, investment services and investment banking. This is not a solicitation to buy or offer to sell or the subject company's securities.

    COMPANY CONTACT:                              INVESTOR CONTACTS:
    Endologix, Inc.                               The Ruth Group
    John McDermott, CEO                           Nick Laudico (646) 536-7030
    (949) 595-7200                                Zack Kubow (646) 536-7020
    www.endologix.com


'/>"/>
SOURCE Endologix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Endologix Receives Nasdaq Letter on Director Independence
2. Endologix Announces Full Commercial Launch of IntuiTrak Express Delivery System
3. American Hospital Management Company Announces the Opening of the New HOSPITAL UNIVERSITARIO DEL RIO-HOSPIRIO in Cuenca, Ecuador
4. Providence Service Corporation Announces Preliminary Results of Annual Meeting of Stockholders
5. New Online Community Answers Hospital Questions about ARRA QHR Announces Launch of theQsphere.com
6. Medizone Announces That Its AsepticSure(TM) Development Program is Reaching Objectives on Two Fronts
7. PDI, Inc. Announces New Business Wins Exceeding $18 Million
8. Pulmo BioTech Inc. Announces Fund Raising Agreement with Moody Capital Solutions, Inc.
9. Eli Lilly and Company Announces New Drug Discovery Initiative
10. QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy
11. NBTY Announces Preliminary Unaudited Net Sales Results for May 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2016)... ... April 30, 2016 , ... ... Radio with Hypnotherapist, Mary O'Maley. What is hypnosis and hypnotherapy and why ... smoking, weight control), pain relief (chronic and acute), birthing processes and medical procedures, ...
(Date:4/30/2016)... ... 30, 2016 , ... Dr. Trevor Gardner, President of the ... a multifaceted agreement which will allow for the research and development of medical ... and Applied Sciences, Allied Health and Nursing will work together to develop new ...
(Date:4/30/2016)... ... 30, 2016 , ... Orlando-based Maximized Living has selected Dr. Nick Wilson of ... Under the care of Maximized Living doctors at the London Olympics in 2012, ... Living is sending the largest contingent of elite chiropractors to Rio to support and ...
(Date:4/29/2016)... ... April 29, 2016 , ... In an article ... shares her enthusiasm for Botox and lip injections, which she underwent in order to ... Coachella Valley Music and Arts Festival. The article explains that Ms. Mirmelli’s situation is ...
(Date:4/29/2016)... ... April 29, 2016 , ... Shamangelic Healing, Sedona Arizona's ... brand Alpha BRAIN and New Mood Daily-Stress Formula for brain optimization and wellness ... to the store is just one more way Shamangelic Healing supports people’s quest ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016 ... development of innovative peptide and gene-based immunotherapeutics and vaccines for ... will be presenting at the 3rd Annual Growth Capital ... 5 th , 2016 at Caesars Palace in Las Vegas, Nevada.  ... am on Wednesday, May 4 th by Dr. ...
(Date:4/27/2016)... MARLBOROUGH, Mass., April 27, 2016  Hologic, Inc. ... Company,s financial results for the fiscal second quarter ... share (EPS) of $0.24 increased 41.2%, and non-GAAP ... $693.3 million increased 5.8% on a reported basis, ... "We posted another good quarter, highlighted ...
(Date:4/27/2016)...   , ... le trimestre, soutenu par une croissance de +42% ... de +16% des ventes aux hôpitaux et cliniques  ... (Euronext : MKEA, FR0010609263 ; OTCQX : MKEAY), inventeur de Cellvizio®, ... chiffre d,affaires pour le premier trimestre clos au ...
Breaking Medicine Technology: